Implantation Failure After IVF: Causes, Tests to Request, and How to Improve Chances

Written by Mannat Fertility Editorial Team | Medically reviewed by Dr. Archana Agarwal, MBBS, DipGO, Medical Director, Mannat Fertility Clinic

Few experiences in fertility treatment are harder to process than a failed transfer, and harder still when the embryo had looked good. It is also among the hardest to explain. Embryo and uterus have to communicate in a way that is precisely timed and molecularly complex, and even where conditions are optimal only around 25–30% of transferred embryos implant successfully. Knowing why failure happens, and what can be investigated before the next attempt, changes what is possible. A failed transfer at Mannat Fertility is treated as a data point rather than a full stop.

What Is Implantation Failure?

One failed transfer is not the same thing as recurrent implantation failure, or RIF. The general definition of RIF is failure to achieve a clinical pregnancy after three or more good-quality embryos have been transferred across at least two separate transfer cycles. That distinction carries weight, because investigation and protocol changes are most warranted in the recurrent setting, and most clearly evidenced there. Not after a single negative.

What Are the Most Common Causes?

Embryo Factors

Chromosomal abnormality in the embryo leads the causes. An aneuploid embryo, meaning one carrying the wrong number of chromosomes, will either fail to implant or else implant and miscarry early. Rates of chromosomal error climb with maternal age, and that is why implantation rates fall as age increases even where the blastocysts look good. Preimplantation genetic testing for aneuploidy, PGT-A, selects the chromosomally normal embryos ahead of transfer, and improved implantation rates are associated with it, particularly in women over 35 and in those with recurrent failure.

Uterine Factors

• Structural abnormalities. Fibroids, submucosal ones especially, along with polyps, scar tissue from Asherman’s syndrome, or a congenital uterine septum. These physically prevent implantation, or reduce blood flow to the endometrium
• Thin or unreceptive endometrium. The lining has to reach adequate thickness, generally at least 7–8 mm, and be receptive at the moment of transfer
• Hydrosalpinx. Fluid inside a blocked fallopian tube refluxes into the uterine cavity and is toxic to embryos. Correcting it surgically before IVF improves outcomes significantly

Other Contributing Factors

• Sperm DNA fragmentation. High levels of DNA damage in sperm affect embryo development after fertilisation, and they do so even where count and motility read normal
• Thrombophilia. Clotting disorders, inherited or acquired, may impair implantation by reducing blood flow through the endometrial vessels
• Immune factors. Natural killer cell activity and other immunological patterns are under study, though the clinical interventions built on those findings remain debated
• Unexplained factors. In a meaningful proportion of recurrent implantation failures no cause is identifiable even after thorough investigation. That is a real limitation of current medicine and not an oversight

What Tests Should You Request After Repeated Failure?

• Hysteroscopy. Direct visualisation of the uterine cavity, to identify and correct structural issues. More sensitive than ultrasound alone at picking up small polyps, adhesions and subtle septae
• Sperm DNA fragmentation test, where it has not already been done, and particularly relevant in unexplained embryo-factor failures
• Thrombophilia screen, particularly where there is personal or family history of clotting events or of recurrent pregnancy loss
• PGT-A on embryos, if it was not performed already, to confirm chromosomal normality ahead of the next transfer
• Endometrial receptivity testing. This times the “window of implantation” through molecular analysis. Evidence for using it routinely is still evolving, though it may help in selected recurrent failure cases

How Can the Next Cycle Be Improved?

What gets adjusted usually flows from what the investigation found:

• Structural issues that hysteroscopy identified are corrected ahead of the next transfer
• A hydrosalpinx, once identified, is managed surgically
• PGT-A gets added, so that euploid embryos can be selected
• The timing or the dose of progesterone luteal support is reviewed
• Where lining response has been suboptimal, the endometrial preparation protocol is reconsidered

If a failed transfer has left you wondering what to do differently, our team at Mannat Fertility will work through the likely causes against your embryo quality and uterine assessment and cycle history before advising on the next steps. Book a consultation with our specialists to map out a revised plan.

This article is for general educational purposes and is not a substitute for personalised medical advice from your fertility specialist or gynaecologist.